Cargando…
Forced enhancer-promoter rewiring to alter gene expression in animal models
Transcriptional enhancers can be in physical proximity of their target genes via chromatin looping. The enhancer at the β-globin locus (locus control region [LCR]) contacts the fetal-type (HBG) and adult-type (HBB) β-globin genes during corresponding developmental stages. We have demonstrated previo...
Autores principales: | Peslak, Scott A., Demirci, Selami, Chandra, Vemika, Ryu, Byoung, Bhardwaj, Saurabh K., Jiang, Jing, Rupon, Jeremy W., Throm, Robert E., Uchida, Naoya, Leonard, Alexis, Essawi, Khaled, Bonifacino, Aylin C., Krouse, Allen E., Linde, Nathaniel S., Donahue, Robert E., Ferrara, Francesca, Wielgosz, Matthew, Abdulmalik, Osheiza, Hamagami, Nicole, Germino-Watnick, Paula, Le, Anh, Chu, Rebecca, Hinds, Malikiya, Weiss, Mitchell J., Tong, Wei, Tisdale, John F., Blobel, Gerd A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958407/ https://www.ncbi.nlm.nih.gov/pubmed/36852088 http://dx.doi.org/10.1016/j.omtn.2023.01.016 |
Ejemplares similares
-
Fertility-preserving myeloablative conditioning using single-dose CD117 antibody-drug conjugate in a rhesus gene therapy model
por: Uchida, Naoya, et al.
Publicado: (2023) -
Development of a forward-oriented therapeutic lentiviral vector for hemoglobin disorders
por: Uchida, Naoya, et al.
Publicado: (2019) -
Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
por: Germino-Watnick, Paula, et al.
Publicado: (2022) -
CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease
por: Demirci, Selami, et al.
Publicado: (2021) -
Pre-existing immunity does not impair the engraftment of CRISPR-Cas9-edited cells in rhesus macaques conditioned with busulfan or radiation
por: Essawi, Khaled, et al.
Publicado: (2023)